Novo Integrated Scie...
OTCPK:NVOS
$
0,00
$
$0,00 (0,00%)
0,00
$
$0,00 (0,00%)
End-of-day quote: 03/31/2026
Novo Integrated Sciences Stock Value
Configure Widget
X
Create Widget
Not an affiliate? https://growth-software.de/partnerprogramm/
Widget copied to clipboard.
Novo Integrated Sciences Company Info
EPS Growth 5Y
0,00%
Market Cap
$0,00 B
Long-Term Debt
$0,00 B
Short Interest
4,23%
Quarterly earnings
07/11/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Founded
Data Unavailable
Industry
Country
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
There are currently no price targets available for this stock.
In the last five quarters, Novo Integrated Sciences’s Price Target has risen from $0,00 to $0,00 - a 100,00% increase.
Top growth stocks in the health care sector (5Y.)
What does Novo Integrated Sciences do?
Novo Integrated Sciences, Inc. (Novo) owns Canadian and the U.S. subsidiaries which provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, diagnostic solutions, unique personalized product offerings, and rehabilitative science.
The company’s decentralized healthcare business model is centered on three primary pill...
Novo Integrated Sciences, Inc. (Novo) owns Canadian and the U.S. subsidiaries which provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, diagnostic solutions, unique personalized product offerings, and rehabilitative science.
The company’s decentralized healthcare business model is centered on three primary pillars to best support the transformation of non-catastrophic healthcare delivery to patients and consumers:
First Pillar – Service Networks: The company delivers multidisciplinary primary care services through an affiliate network of clinic facilities, small and micro footprint sized clinic facilities primarily located within the footprint of box-store commercial enterprises, clinic facilities operated through a franchise relationship with the company, and corporate operated clinic facilities.
Second Pillar – Technology: The company develops, deploys, and integrates sophisticated interconnected technology, interfacing the patient to the healthcare practitioner, thus expanding the reach and availability of the company’s services, beyond the traditional clinic location, to geographic areas not readily providing advanced, peripheral based healthcare services, including the patient’s home.
Third Pillar – Products: The company develops and distributes effective, personalized health and wellness product solutions, allowing for the customization of patient preventative care remedies and ultimately a healthier population. The company’s science-first approach to product innovation further emphasizes the company’s mandate to create and provide over-the-counter preventative and maintenance care solutions.
Innovation through science, combined with the integration of sophisticated, secure technology, assures Novo Integrated of continued cutting-edge advancement in patient-first platforms.
First Pillar – Service Networks for Hands-on Patient Care
The company’s clinicians and practitioners provide certain multidisciplinary primary healthcare services, and related products, beyond the medical doctor first level contact identified as primary care. The company’s clinicians and practitioners are not licensed medical doctors, physicians, specialists, nurses, or nurse practitioners. The company’s clinicians and practitioners are not authorized to practice primary care medicine, and they are not medically licensed to prescribe pharmaceutical based product solutions.
The company’s team of multidisciplinary primary healthcare clinicians and practitioners provides assessment, diagnosis, treatment, pain management, rehabilitation, education, and primary prevention for a wide array of orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations, through the company’s 14 corporate-owned clinics, a contracted network of affiliate clinics, and eldercare related long-term care homes, retirement homes, and community-based locations in Canada.
The company’s specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy (including pre- and post-partum), acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women’s pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning programs, including event and game coverage, and private personal training.
Additionally, the company continues to expand its patient care philosophy of maintaining an ongoing continuous connection with its current and future patient community, beyond the traditional confines of brick-and-mortar facilities, by extending oversight of patient diagnosis, care, and monitoring directly through various Medical Technology Platforms either in-use or under development.
The occupational therapists, physiotherapists, chiropractors, massage therapists, chiropodists, and kinesiologists contracted by Novo Healthnet Limited, a wholly owned subsidiary of Novo Integrated (‘NHL’), to provide occupational therapy, physical therapy, and fall prevention assessment services are registered with the College of Occupational Therapists of Ontario, the College of Physiotherapists of Ontario, the College of Chiropractors of Ontario, the College of Massage Therapists of Ontario, the College of Chiropodists of Ontario, and the College of Kinesiologists of Ontario regulatory authorities.
The company’s strict adherence to public regulatory standards, as well as self-imposed standards of excellence and regulation, has allowed it to navigate with ease through the industry’s licensing and regulatory framework. Compliant treatment, data, and administrative protocols are managed through a team of highly trained, certified healthcare and administrative professionals. The company and its affiliates provide service to the Canadian property and casualty insurance industry, resulting in a regulated framework governed by the Financial Services Commission of Ontario.
Affiliate Clinics
In order to strengthen the company’s position within the Canadian Preferred Provider Network (‘PPN’), it has built a contracted affiliate relationship with clinics across Canada, with a majority of its affiliate clinics located in Ontario province, and other affiliate clinics located in Alberta, Nova Scotia, and Newfoundland. The PPN receives referrals from insurance companies, licensed in Canada, for patients in need of specific multidisciplinary primary healthcare solutions.
The services provided by the company’s affiliate clinics are consistent with the multidisciplinary primary healthcare services provided by its own corporate clinics. While each affiliate clinic may provide additional unique healthcare solutions, all affiliate clinics must meet specific criteria established under the PPN, creating a single standard of excellence across all clinics within its network.
LA Fitness U.S. and Canada Micro Clinics
In September 2019, through the company’s U.S. subsidiary Novomerica Health Group, Inc. (‘Novomerica’) and its Canadian subsidiary, NHL, the company entered into exclusive Master Facility License Agreements (‘License Agreement’) to establish and operate reduced footprint clinics, or ‘micro-clinics’, to provide outpatient physical and/or occupational therapy services and related products within LA Fitness facilities in both the U.S. and Canada. In March 2020, as a result of guidelines issued by local, state, federal, and provincial authorities due to the COVID-19 pandemic, LA Fitness U.S. and Canada closed all facilities nationwide. As a result, all contractual terms and conditions of both the company’s U.S. and Canada Master Facility License Agreements were placed on hold through fiscal year 2021, with all parties expressing the intent to amend both the U.S. and Canada License Agreements and related timelines to launch the company’s LA Fitness micro-clinic facilities as ‘normal’ activity resumes in the LA Fitness U.S. and Canada facilities.
On December 15, 2021, NHL entered into an Amended and Restated Master Facility License Agreement (the ‘Amended and Restated Canada License Agreement’) with LAF Canada Company (‘LA Fitness Canada’). The Amended and Restated Canada License Agreement had the effect of removing NHL’s obligation to develop and open a certain number of facilities within certain designated time periods, and revising the default provisions such that certain defaults will result only in termination with respect to a specific facility, rather than of the license itself. As a result of the Amended and Restated Canada License Agreement, NHL may continue to develop and open additional facilities for business. The initial location is in the Brampton Ontario LA Fitness facility, with more locations to follow in Ontario province.
Eldercare
The company’s eldercare related operations provide physiotherapy (‘PT’), occupational therapy (‘OT’), assessment, and application assistance for assistive devices, fall prevention programs, community-based strengthening, and general flexibility exercise classes, rehabilitative strategies, and continuing education to eldercare clients, including caregivers and family members as applicable, in various long-term care homes, retirement homes, and community-based locations across the province of Ontario, Canada.
As a result of NHL’s September 2013 asset acquisition of Peak Health LTC Inc, an Ontario corporation formed in 2006, NHL has more than 20 years of experience providing certain multidisciplinary related healthcare services and products to the eldercare community. In 2017, based on the philosophical overlap and synchronicity between PT and OT, NHL launched its occupational therapy sector of services for the company’s eldercare clients. NHL’s eldercare focused OT and PT services and products are in direct competition with the top providers in this sector. The company offers an extensive roster of both OT and PT clinicians certified by the Ministry of Health for assistive device assessment under the Assistive Device Program, which, when the individual meets the criteria, allows its eldercare clients access to significant funding subsidies to purchase varying mobility aids (such as walkers, wheelchairs, seating, and power wheelchairs/scooters).
Additionally, the company’s proprietary Electronic Rehabilitation Record and Management Reporting software solution provides it the ability to deliver each eldercare location with a wide array of detailed PT and OT reports that include, among other things: client specific treatment details, identifying cost and optimization possibilities, outlining a wide variety of client outcome measurements, analyzing overall contract effectiveness, and producing indicators which assist the NHL team to target opportunities for improved team efficiency. This software comes with an ability to provide a graphically illustrated ‘report card’ for contribution to annual, interdisciplinary care conferences with staff and family members, as well as fall reporting capacities, which are central to many homes’ fall prevention committee meetings. Additionally, data generated by the software allows members from both the NHL team and the eldercare facility team to identify residents who fall frequently and allows for the interdisciplinary team to put strategies in place to better reduce a resident’s ‘fall-risk’.
NHL has created and delivers, through online virtual technology, a variety of eldercare oriented educational in-service programs which include topics, such as nursing restorative education, back education, and other eldercare-relevant topics, such as osteoporosis, fall prevention, wheelchair positioning, and least restraints. NHL has designed its virtual online education in-service programs and modules to be presented in a variety of formats to facilitate the different capacity and styles of learning common to senior-aged individuals.
The company’s eldercare PT services are provided as follows:
Long-Term Care Homes: NHL contracts with long-term care homes to provide individualized, onsite PT and group exercise classes for its residents. Registered physiotherapists are assisted by on-site support personnel to deliver individualized care, based on assessed needs, and with a goal of assisting each resident to attain and maintain their highest level of function possible with their activities of daily living. These services are primarily funded by the Ontario Ministry of Long-Term Care (‘MLTC’). The NHL team assists in providing assistive device assessments allowing residents access to funding assistance for varying mobility aids (such as walkers, wheelchairs, seating, and power wheelchairs/scooters). In addition to providing PT services, the company’s team assists the long-term care home’s interdisciplinary team in the homes’ annual care conferences with its residents. Through the provision of education regarding nursing restorative programming, the company’s team assists the long-term care home’s team in back education, fall prevention, and many other subjects related to PT or physical health and wellness. The NHL team works together with the interdisciplinary team to assist with mandatory coding of Canada’s Resident Assessment Instrument Minimum Data Set (‘RAI-MDS’), which is the standardized assessment tool required for the home to access payment from the MLTC for each resident. Additionally, through NHL’s proprietary software, the homes have access to abundant reporting solutions to help provide objective and quantitative measures for their continuous quality improvement program. NHL’s proprietary software provides the company’s eldercare client locations with the unique ability to log in and access multiple data points related to a multitude of therapy services provided to its residents, allowing for detailed, rapid reporting and accountability.
Retirement Homes: The company contracts with client retirement homes to provide individualized physiotherapy and group exercise classes to the retirement homes’ residents. Registered physiotherapists are assisted by the onsite support personnel to deliver individualized care based on assessed needs, again with a goal of assisting the residents participating in therapy to attain and maintain their level of function related to the activities of daily living. These services are partially funded by the individual and partly funded by the MLTC. Similar to the long-term care sector, the company’s team assists with education of the nursing/interdisciplinary team, provides in-depth service reports to the homes to measure desired service delivery, and its proprietary software allows for the retirement home to have the same unique login capacity. In addition to the services, some of the residents in the retirement homes, and as applicable the resident’s family members, can request and authorize receiving an increased level of physiotherapy related services available privately on a fee-for-service basis paid by the individual. In addition, access to Registered Occupational Therapists, Massage Therapists, and Speech Language Pathologists is also offered on a fee-for-service basis.
Community Based Home Care Physiotherapy: Throughout the province of Ontario, the MLTC operates 14 Ontario Health AtHome branches (‘OHaH’), which are health authorities responsible for regional administration of public healthcare services. OHaH serves as contact points, information clearing houses, referral resources, and assessment/care coordinators for eligible residents who need healthcare assistance at home or a safer place to live through aging at home strategies that can be put in place by healthcare providers. Through service contracts, OHaH engages ‘cluster providers’ to provide services to clients living in the community, clients living at home, or clients living in a retirement home. These service contracts are funded by the MLTC.
NHL is a ‘cluster provider’ sub-contractor for home care physiotherapy in the Northeast OHaH, which encompasses more than 565,000 people across 400,000 square kilometers and five sub-regions. Through this subcontract arrangement, it provides one-on-one physiotherapy assessment and treatment to clients who cannot easily access outpatient services due to mobility challenges. Primarily, these clients are elderly with multiple co-morbidities, although some clients are not elderly and are instead simply post-operative with mobility challenges.
Community Based Group Exercise Classes & Fall Prevention Programs: NHL has contracted with two ‘cluster providers’ to provide group exercise classes and fall prevention programs (consisting of an assessment accompanied by education and group exercise classes) in three separate OHaH branches (Central, Toronto Central, and Central East), which encompass the Greater Toronto area with an estimated aggregate population of 4.4 million people. In 2013, the MLTC introduced several initiatives designed to assist seniors in maintaining an active and healthy lifestyle while still living at home. Under the 2013 initiative, exercise instructors under contract with NHL deliver group exercise classes over a 48-week period each year.
In addition, another component of the 2013 MLTC initiative is the delivery of fall prevention programs with entry and exit assessments completed by specialized registered providers, such as kinesiologists and physiotherapists, with the assistance of exercise instructors for the group class and education portion of the program. The goal of these classes is to assess seniors’ general health status, identify defined levels of risk pertaining to balance and falling, and educate seniors about fall prevention through a combination of increased knowledge, and teaching exercises designed to improve strength and balance.
Community-based Outpatient Clinics: NHL provides outpatient physiotherapy, chiropractic, and laser technology services through a community-based clinic in the province of Ontario. The services provided at the clinic are funded by Motor Vehicle Accident treatment plans, extended health benefits insurance coverage, or private payment. A portion of the services provided at the clinic are funded by the MLTC in the form of Episodes of Care, and these services are specifically targeted to be delivered to clients who meet the following criteria: Aged 65 years of age and older, or aged 18 years of age and younger, and are post-operative, or have just been discharged from a hospital, or are receiving services from the Ontario Disability Services Program or Ontario Works.
The company’s eldercare OT services are provided through two separate sectors, as follows:
Long-Term Care Sector: The company contracts with client homes to provide the following OT services:
Assessments and interventions to support maintenance and restoration of function related to seating, mobility, positioning for self-care, prevention of pressure ulcers, falls, and use of restraints,
Speech language pathology services, including evaluation and treatment by registered speech language pathologists.
Swallowing and eating assessments and interventions,
Cognitive behavioral assessments and care planning.
The company’s occupational therapists have specialized training in mobility, providing assistive device assessments when required. This service is funded primarily by the MLTC.
Retirement Home & Community: The company provides the following OT services through individual contracts with private payers: Home safety assessments, functional assessments, in-home activities of daily living assessments, assessment and completion of applications for assistive devices (mobility aids), custom seating and mobility consultations, case management services, and speech language pathology services, including evaluation and treatment by registered speech language pathologists.
Second Pillar – Interconnected Technology for Virtual Ecosystem of Services, Products, and Digital Health Offerings
Decentralization through the integration of interconnected technology platforms has been adopted and is thriving in a variety of sectors and industries, such as transportation (Uber, Lyft), real estate (Zillow, Redfin, Airbnb, VRBO), used car sales (Carvana, Vroom), stock and financial markets (Robinhood, Acorns, Webull), and so many other sectors. Yet decentralization of the non-critical primary care and wellness sector of healthcare is lagging significantly in capability and benefit for patient access and delivery of services and products. The COVID pandemic has taught both patients and healthcare providers the viability, importance, and benefits of decentralized access to primary care simply through the rapid adoption of telehealth/telemedicine.
The company’s focus on a holistic approach to patient-first health and wellness, through innovation and decentralization, includes maintaining an ongoing continuous connection with its current and future patient community, beyond the traditional confines of brick-and-mortar facilities, by extending oversight of patient evaluation, diagnosis, treatment solutions, and monitoring directly through various Medical Technology Platforms and periphery tools either in-use or under development. Through the integration and deployment of sophisticated and secure technology and periphery diagnostic tools, the company is working to expand the reach of its non-critical primary care services and product offerings, beyond the traditional clinic locations, to geographic areas not readily providing advanced primary care service to date, including the patient’s home.
Novo Connect
Novo Connect, the company’s proprietary mobile application with a fully securitized tech stock, telemedicine/telehealth, and remote patient monitoring, is a secure, cloud-based health and commerce web application intended to assist patients as they explore, connect, manage, and have direct control of their personalized health and wellness needs. Novo Connect is designed to integrate the company’s interconnected technology and provide the patient a single platform with a robust healthcare ecosystem of services, products, and digital health offerings.
In October 2021, the company launched MiTelemed+, Inc. (‘MiTelemed’), a joint venture with EK-Tech Solutions Inc. (‘EK-Tech’). MiTelemed operates, supports, and expands access and functionality of iTelemed, EK-Tech’s enhanced proprietary telehealth platform. MiTelemed+, through the iTelemed platform, allows the company to offer the patient and the practitioner a sophisticated and enhanced telehealth interaction. Through the interface of sophisticated peripheral based diagnostic tools operated by skilled support workers in the patient’s remote location, the practitioner’s ability and comfort to provide a uniquely comprehensive evaluation, diagnosis, and treatment solution is dramatically elevated.
The system for delivery and access to primary care is fragmented, requiring patients to use multiple access points, portals, and applications to track various practitioner and health plan interactions for which each practitioner and health plan maintains separate records. Too many times, as a patient ages, the current systems make it almost impossible to have a central data set of a patient’s health history, many times losing various time periods of health history. Novo Connect is intended to empower the patient by providing a single platform that offers care services, tracking, and secure recordkeeping to better navigate care choices.
Specific to non-critical care, the patient-practitioner relationship is shifting away from on-site visits to primary medical centers with mass-services, and to the patient’s home and micro-clinics. Novo Connect is intended to provide ‘ease-of-access’ in the patient/practitioner interaction for non-critical care diagnosis and subsequent treatment, minimizing the degradation of non-critical health conditions to critical conditions, as well as allowing for more cost-effective healthcare distribution. The services and products available through Novo Connect may be provided either directly by the company or an affiliated network of service or product providers across a variety of specialties.
Novo Connect is intended to provide a suite of secure, reliable engagement features, including, but not limited to,
Connect Now: a real-time scheduling solution to connect clinic practitioners and physicians.
Connect Storage: secure document storage.
Connect Community: a community chat forum to share and discuss various conditions, to include curated ‘channels’ offering health and wellness solutions and insight.
Connect CarePlan: a patient-specific care plan developed by providers, augmented with product and service solutions, to address various conditions.
Remote bill pay.
Remote patient monitoring interface.
As of August 31, 2024, Novo Connect was in limited commercialization through certain of the company’s corporate-owned clinics, with expanded commercialization intended to launch in the spring of 2025.
Telemedicine/Telehealth
The COVID-19 pandemic has taught both patients and healthcare providers the viability, importance, and benefits of telemedicine technology for non-catastrophic primary care. Telemedicine is transforming traditional approaches to healthcare by providing ease of access and reduced costs for patients, particularly in areas with limited access to both clinicians and medically licensed providers. In a post-pandemic global environment, telemedicine is more readily being adopted by patients, practitioners, clinicians, medical licensed providers, and health insurers for limited diagnostic and treatment solutions.
Through both internal development and partnerships, the company is working to provide the next generation of telehealth technology to offer the patient and the practitioner a sophisticated and enhanced telehealth interaction using an interface of sophisticated peripheral based diagnostic tools, such as a blood pressure reading device, a derma scope, an ophthalmoscope, otoscope, and other add-ons operated by skilled support workers in the patient’s remote location. This enhanced telehealth experience allows for the practitioner and patient to have a much higher level of ability and comfort to provide a uniquely comprehensive evaluation, diagnosis, and treatment solution, thus dramatically elevating the effectiveness of virtual visits that are more resource efficient and as effective as a physical visit.
Remote Patient Monitoring (‘RPM’)
The company’s RPM program is intended to empower a patient to have direct control of collecting and monitoring real-time vital sign information while maintaining a direct technology link from patient to clinician or medical practitioner. The transfer of vital information from home to clinic, or patient to clinician, allows for the delivery of high quality, non-redundant diagnostic based proactive healthcare. The implementation of in-clinic patient metrics equivalent to those derived via a remote application in the home environment is the first step in engaging patient retention to remote review. The RPM program allows the company to further expand on its patient-first care philosophy of maintaining an ongoing connection with its patient community, beyond the traditional confines of a clinic, extending oversight of patient care and monitoring directly into the patient’s home.
Third Pillar – Health and Wellness Products
As the company’s patient base grows through the expansion of its corporate-owned clinics, its affiliate network, its micro-clinic facility openings, its interconnected technology platforms, and other growth initiatives, the development and distribution of high-quality wellness product solutions is integral to offering effective product solutions allowing for the customization of patient preventative care remedies and ultimately a healthier population, and maintaining an ongoing relationship with the company’s patients through the customization of patient preventative and maintenance care solutions.
The company’s product offering ecosystem has been built through strategic acquisitions and engaging in licensing agreements with partners that share its vision to provide a portfolio of products that offer an essential and differentiated solution to health and wellness globally. The company’s 2021 acquisitions of Acenzia, PRO-DIP, LLC (‘PRO-DIP’), and Terragenx Inc. (‘Terragenx’) support this Third Pillar. The company owns a 91% controlling interest in Terragenx. On March 15, 2022, PRO-DIP was issued U.S. Patent No. 11,273,965 by the U.S. Patent and Trademark Office. The ‘965 patent relates to PRO-DIP’s novel technology for manufacturing its oral supplement pouches. On April 4, 2022, NHL was granted a Natural Product Number (NPN) by Health Canada for IoNovo GO Iodine, which is the company’s fourth iodine related product to recently be granted a NPN by Health Canada, following IoNovo Pure Iodine, IoNovo Iodide, and IoNovo for Kids pure iodine oral spray.
Acenzia Inc.
Acenzia Inc. (‘Acenzia’) was acquired by NHL in June 2021. Acenzia is in the business of providing nutraceutical health solutions through advanced bio-science research and development, proprietary manufacturing, and personalized diagnostics. In addition, Acenzia has developed a multiple international jurisdiction patented technology platform called Zgraft, using zebrafish, which enables rapid analysis of cancer cells, offering cancer patients and their healthcare providers prediction of early metastasis and drug sensitivity, thereby providing important information for diagnosis and treatment.
Acenzia, founded in 2015, is licensed by multiple international government agencies, including Health Canada, the U.S. FDA, and the European Union for Good Manufacturing Practices (GMP) for over-the-counter and dietary supplement manufacturing. In addition, Acenzia maintains multiple third-party licenses, including from the National Sanitation Foundation International (NSF) for meeting the required public health standards for manufacturing food, nutrition, and supplements. Acenzia is dedicated to the creation of innovative therapeutics and diagnostics that enable individualized health optimization.
Acenzia’s 36,000 square foot facility is located in Windsor, Ontario, Canada, and includes Class 100 pharmaceutical grade cleanrooms and certified laboratories from which Acenzia creates and manufactures evidence-based dietary, nutraceutical, and food products that can be validated through personalized diagnostics.
PRO-DIP, LLC
PRO-DIP, LLC (‘PRO-DIP’), founded in 2015 and based in San Jose, California, was acquired by the company in May 2021. PRO-DIP has developed and commercialized its proprietary, patent-pending ION Energy oral pouch that delivers flavorful bursts of vitamins and natural energy supplements through small, semi-permeable sachets placed in the mouth, between the gum and cheek or lip. The initial burst of supplements is followed by extended absorption of the nutrients, providing long-lasting energy, even at high-exertion levels. With its hands-free ease of consumption, the ION energy-rich pouch is an alternative to traditional sports supplements. On March 15, 2022, PRO-DIP was issued U.S. Patent No. 11,273,965 by the U.S. Patent and Trademark Office. The ‘965 patent relates to PRO-DIP’s novel technology for manufacturing its oral supplement pouches.
In addition to the ION Energy oral pouch, PRO-DIP is developing other pouch types for applications, such as hydration, immunity, multi-vitamin, antioxidants, creatine, and sleep.
The PRO-DIP oral pouch delivery system offers broad market applications related to nutritionally focused products and medicinal based formulations. The dissolvable oral pouch serves as the delivery mechanism for certain medications, normally swallowed in pill or tablet format, between the cheek and gum for buccal absorption into the mouth’s small blood vessels.
Terragenx Inc. and Iodine Micro-nutrient
On November 17, 2021, NHL acquired a 91% controlling interest in Terragenx Inc., and the company acquired the intellectual property portfolio for the unique formulation and manufacturing capability to produce a water-soluble, iodine micro-nutrient oral spray that is 100% pure and natural, with no chemicals, no plastics, and no alcohol (‘IoNovo’). The IoNovo oral spray line of products is designed to be delivered via oral spray, which is proven to be significantly more effective in absorption than pill or gel capsules, and is FDA and Health Canada approved for over-the-counter and e-commerce distribution.
Iodine is a naturally occurring element and essential nutrient used by the thyroid gland to manufacture necessary hormones in the human body. Iodine is recognized as a world-class disinfectant and is one of nature’s finest microbial killers of bacteria and virus deactivators. For decades, the global medical community has recognized iodine as an essential micronutrient that assists the thyroid to produce T3 and T4 hormones needed for a healthy metabolism, immune system, increased energy levels, and cognitive development. Additionally, iodine is known to promote healthy skin, nails, and hair.
While iodine alone cannot be ingested as a stand-alone ingredient, through the acquisition of Terragenx and the iodine IP, the company has acquired the intellectual property for iodine in an aqueous form that can be safely ingested and has been proven to kill viruses, bacteria, and protozoa when sprayed onto mucous membranes, the entry points for various airborne viruses.
The company has been granted Natural Product Numbers (NPN) by Health Canada for each of IoNovo GO Iodine, IoNovo Pure Iodine, IoNovo Iodide, and IoNovo for Kids pure iodine oral spray. An NPN is a product license assessed and granted by Health Canada to commercialize a product that is found to be safe, effective, and of high quality. In addition, Turkey’s Ministry of Health has granted a registration number and provided regulatory approval for both IoNovo for Kids and IoNovo Iodine as dietary supplements determined to be safe, effective, of high quality, and eligible for sale in Turkey.
Intellectual Property and Patents
The company has acquired intellectual property, including patents, related to health sciences, personal diagnostics, and product applications which include:
U.S. Patent No. 11,273,965 issued by the U.S. Patent and Trademark Office on March 15, 2022, for oral and/or buccal delivery pouch and the method of making same. The ‘965 patent relates to PRO-DIP’s novel technology for manufacturing its oral supplement pouches. PRO-DIP’s innovative, patented oral supplement pouch delivery system technology provides for broad market applications related to nutritionally focused products and medicinal based formulations. PRO-DIP’s initial oral pouch commercial product offering, the ION Energy pouch, is designed for the delivery of flavorful bursts of vitamins and natural energy supplements through small, semi-permeable sachets placed in the mouth, between the gum and cheek or lip. The initial burst of supplements is followed by extended absorption of the nutrients, providing long-lasting energy, even at high-exertion levels. With its hands-free ease of consumption, the energy-rich pouches are an alternative to traditional sports supplements and deliver a daily serving of natural vitamins and nutrients. The invention of the pouch delivery system for nutraceuticals continues to gain mainstream interest from health product manufacturers, medical organizations, big pharma, the military, space organizations, CBD/hemp companies, humanitarian aid groups, and the list goes on.
U.S. Patent No. 10,760,060B2, issued by the U.S. Patent and Trademark Office on September 1, 2020, for injection and incubation of circulating tumor cells from a cancer biopsy in zebrafish for accelerated prediction of cancer progression and response to treatment. Referred to as Zgraft, this is a multiple international jurisdiction patented personalized diagnostic technology platform which, using zebrafish, enables rapid analysis of cancer cells, offering cancer patients and their healthcare providers prediction of early metastasis and drug sensitivity, thereby providing important information for diagnosis and treatment. The Zgraft platform models tumor progression and analyzes a cancer cell’s response to various treatments by transplanting human tumor tissue into a zebrafish, allowing researchers to test an individual’s tumor cells under various conditions to see how they might respond to certain drug combinations and how the cancer progresses — all without exposing patients to the adverse effects of trying drug combinations that, ultimately, aren’t effective for their cases. Essentially, by taking a sample of cancer cells from a patient’s own tumors and studying them in a variety of conditions, doctors can now provide a more accurate prognosis of that individual’s case.
Intellectual property for generic primary and sub-primary drug formulations (known as bioequivalence) of name brand pharmaceutical reference products related to usage as injectables, ophthalmic, and topical applications.
Intellectual property for proprietary designs for a cannabis dosing device, TruDose, which provides real-time analysis for the amount of THC/CBD in the smoke/vapor stream, after the heat point, allowing that once the device has detected the medically prescribed pre-set amount of THC/CBD has been detected, the device shuts off the flow of smoke/vapor so that only the pre-determined dose can be inhaled. The TruDose device is designed and intended to create assurance to delivered doses, potentially allowing for broader medical application adoption.
Iodine and IoNovo related intellectual property, patents, and patent pending as follows:
Canada patent pending for spray devices for dispensing aqueous iodine, and methods of making and using spray devices that dispense aqueous iodine.
U.S. patent pending for controlled gaseous iodine sublimation from solid iodine for atmospheric iodine nutrition, disinfection, and therapeutic uses.
U.S. patent pending for an apparatus to produce atmospheric nutritional & disinfectant iodine.
U.S. patent pending for automated high output aqueous iodine production and bottling system.
Business Growth Initiatives
Key elements of the company’s business growth initiatives are to increase market share in Canada through organic growth, asset acquisition, and affiliate network expansion for both its clinic and eldercare operations; expand operations into the United States through opening micro-clinic facilities through the company’s Canada and U.S. LA Fitness Master Facility License Agreements; further development and usage of Novo Connect and telemedicine/telehealth medical technology platform; develop and launch its remote patient monitoring medical technology platform; build an intellectual property and patent portfolio; expand the company’s posture, stride, and kinetic body movement scanning technologies and protocols; and launch the company’s exclusive medicinal cannabidiol (‘CBD’) product platform based in Canada.
LA Fitness U.S. and Canada License Agreement & Guaranty for Micro Clinics
In September 2019, through its U.S. subsidiary Novomerica Health Group, Inc. (‘Novomerica’) and its Canadian subsidiary, Novo Healthnet Limited, the company entered into exclusive Master Facility License Agreements (‘License Agreement’) to establish and operate reduced footprint clinics, or ‘micro-clinics’, to provide outpatient physical and/or occupational therapy services and related products within LA Fitness facilities in both the U.S. and Canada. In March 2020, as a result of guidelines issued by local, state, federal, and provincial authorities due to the COVID-19 pandemic, LA Fitness U.S. and Canada closed all facilities nationwide. As a result, all contractual terms and conditions of both the company’s U.S. and Canada Master Facility License Agreements were placed on hold through fiscal year 2021, with all parties expressing the intent to amend both the U.S. and Canada License Agreements and related timelines to launch its LA Fitness micro-clinic facilities as ‘normal’ activity resumes in the LA Fitness U.S. and Canada facilities.
On December 15, 2021, NHL entered into an Amended and Restated Master Facility License Agreement (the ‘Amended and Restated Canada License Agreement’) with LAF Canada Company (‘LA Fitness Canada’).
Government Regulation and Healthcare Regulation
Additionally, on January 16, 2009, the United States Department of Health and Human Services (‘HHS’) released the final rule (implemented on October 1, 2015) mandating that providers covered by the Administrative Simplification Provisions of the Health Insurance Portability and Accountability Act of 1996 (‘HIPAA’), including the company’s clinics, comply with ICD-10.
The company is subject to any federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA.
The company anticipates that its prospective medicinal CBD products will be federally legal in the United States in that they will contain less than 0.3% of THC in compliance with the 2018 Farm Bill guidelines and will have no psychoactive effects on its patients’ and customers’ bodies.
All of the company’s Medical Technology Platforms are subject to governmental healthcare regulations in Canada, including, but not limited to, the Canada Health Act.
History
The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Novo Integrated Sciences, Inc. in July 2017.
This stock is not included in this month's Starter.
The Starter plan only unlocks analyses for the 25 stocks tracked over the past month. With the Compact plan, you get access to all stocks from Germany and the USA – with Premium, worldwide access.
Stock added to your portfolio . To add it to another portfolio, click here.
